Oral Anticoagulation Versus Left Atrial Appendage Occlusion Added to Direct Oral Anticoagulation in Patients with Stroke Despite Oral
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 380 participants.
Also called NCT06869811
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 380 participants
- Sponsor
- Registry
-
NCT06869811
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Spain
- Registry status
- Recruiting
Technical summary
Registry record NCT06869811. Randomized; single masking; primary purpose treatment. Start 2024-07-22 (actual); primary completion 2027-02-22 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Oral Anticoagulation Versus Left Atrial Appendage Occlusion Added to Direct Oral Anticoagulation in Patients with Stroke Despite Oral
- Acronym
- ADDLAAO
- Condition
- Left Atrial Appendage Closure
- Intervention (Device)
- LAA Closurse
- Lead sponsor
- Hospital Clinic of Barcelona
- Collaborator
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- Collaborator
- Hospital San Carlos, Madrid
- Collaborator
- Hospital Álvaro Cunqueiro
- Collaborator
- Hospital Universitari de Bellvitge
- Collaborator
- University of Salamanca
Record details
- Record id
cardio:ct-nct06869811- Content hash
4467fbe74595b6b033ac5c9ff6896cfabb5794bd3293aa4a897d0564028a2dec